Literature DB >> 17636072

Effects of IV glucose and oral medium-chain triglyceride in patients with VLCAD deficiency.

M C Ørngreen1, M G Nørgaard, B G M van Engelen, B Vistisen, J Vissing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17636072     DOI： 10.1212/01.wnl.0000265854.41013.84

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Treatment Opportunities in Patients With Metabolic Myopathies.

Authors:  Mette Cathrine Ørngreen; John Vissing
Journal:  Curr Treat Options Neurol       Date:  2017-09-21       Impact factor: 3.598

Review 2.  State of the art in muscle lipid diseases.

Authors:  W C Liang; I Nishino
Journal:  Acta Myol       Date:  2010-10

3.  Combined HIIT and Resistance Training in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: A Case Report.

Authors:  Alba M Herrera-Olivares; Jose A Fernández-Luque; Carmen Paradas; Alejandro Lucia; Alfredo Santalla
Journal:  Front Physiol       Date:  2019-05-28       Impact factor: 4.566
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.